Showing results (1411-1420 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|December 8, 2018
MDR1 in immunity: friend or foe?Marion Bossennec, Anthony Di Roio, Christophe Caux, et al.Oncoimmunology|December 8, 2018
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma modelsVassilis Genoud, Eliana Marinari, Sergey I Nikolaev, et al.Oncoimmunology|December 8, 2018
Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatomaYung-Chang Lin, Chen-Yu Hsu, Sheng-Kai Huang, et al.Oncoimmunology|December 8, 2018
Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burdenJan Budczies, Anja Seidel, Petros Christopoulos, et al.Oncoimmunology|December 8, 2018
Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarateLorenzo Galluzzi, Guido KroemerOncoimmunology|June 13, 2022
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myelomaTobias Bexte, Jamal Alzubi, Lisa Marie Reindl, et al.Oncoimmunology|June 27, 2022
Immune suppressive function of IL-1α release in the tumor microenvironment regulated by calpain 1Dandan Lin, Yu Mei, Lei Lei, et al.Oncoimmunology|July 8, 2022
Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activationTeng He, Zhixing Hao, Mingjie Lin, et al.Oncoimmunology|November 16, 2020
Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysisKe Zhao, Zhenhui Li, Yong Li, et al.Oncoimmunology|March 3, 2020
Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiationMaciej Kujawski, Mark Sherman, Susanta Hui, et al.Pageof 380